A7655

Atenolol

≥98% (TLC), powder, β₁-adrenoceptor antagonist

• Synonim(y): (±)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide, 4-[2′-Hydroxy-3′-(isopropylamino)propoxy]phenylacetamide
• Wzór empiryczny (zapis Hilla): C₁₄H₂₂N₂O₃
• Numer CAS: 29122-68-7
• Masa cząsteczkowa: 266.34
• NACRES: NA.77
• PubChem Substance ID: 24277748
• UNSPSC Code: 12352200
• EC Number: 249-451-7
• MDL number: MFCD00057645
• Assay: ≥98% (TLC)
• Form: powder

Właściwości

• Nazwa produktu: Atenolol, ≥98% (TLC), powder
• Quality Segment: 200
• assay: ≥98% (TLC)
• form: powder
• color: white to off-white
• solubility: H₂O: 0.3 mg/mL, DMSO: 18 mg/mL, ethanol: 3.4 mg/mL
• originator: AstraZeneca
• SMILES string: CC(C)NCC(O)COc1ccc(CC(N)=O)cc1
• InChI: 1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
• InChI key: METKIMKYRPQLGS-UHFFFAOYSA-N
• Gene Information: human ... ADRB1(153) ; rat ... Adrb1(24925)

Opis

Application

Atenolol is a β-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties.

Biochem/physiol Actions

Selective β₁-adrenoceptor antagonist; antihypertensive; antianginal; antiarrhythmic.

Features and Benefits

This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Shelf-life of the solid is at least three years.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• Co się dzieje?: WGK 2
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable
• PPE (środki ochrony indywidualnej): Eyeshields, Gloves, type N95 (US)